ZYEPTI
LIVE

Serial Number

79291195

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Feb 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ZYEPTI Trademark

Serial Number: 79291195 • Registration: 6436392

ZYEPTI is a trademark filed by H. Lundbeck A/S on February 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC. (64 trademarks)

BOTHELL, WA 98011

Entity Type: 03

Trademark Details

Filing Date

February 25, 2020

Registration Date

August 3, 2021

Published for Opposition

May 18, 2021

Goods & Services

Pharmaceuticals and medical preparations and substances for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; Preparations, substances, reagents and agents for diagnostic and medical purposes, namely, for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 7, 2022 FICS
FINAL DISPOSITION PROCESSED
Jan 7, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 3, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 3, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 18, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 18, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 17, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2021 CRFA
ASSIGNED TO LIE
Mar 25, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 24, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 15, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 15, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 15, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2021 CRFA
ASSIGNED TO LIE
Feb 25, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 25, 2020 TROA
CHANGE OF OWNER RECEIVED FROM IB
Nov 9, 2020 DCPN
REFUSAL PROCESSED BY IB
Oct 11, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 23, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 23, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 18, 2020 RFCR
APPLICATION FILING RECEIPT MAILED
Aug 18, 2020 MAFR
NON-FINAL ACTION WRITTEN
Aug 17, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 13, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 6, 2020 REPR